Google Ads telemedicine certification in the US is a two-step process. A telehealth provider first gets LegitScript’s Healthcare Merchant Certification, then applies to Google through its healthcare application. Until both are done, Google won’t serve the brand’s prescription drug service ads or let it keyword-target drug names like semaglutide or tirzepatide.
Policy checked on October 24, 2026.
What Google’s US telemedicine policy says
Google’s Healthcare and medicines policy accepts one accreditation for US telemedicine, LegitScript, and requires a separate Google certification on top. The US section reads:
“Google allows telemedicine providers if they’re accredited by LegitScript’s Healthcare Merchant Certification Program, which offers telemedicine certification to websites that provide virtual healthcare services and facilitate prescribing.” … “Advertisers must also be certified with Google.” (Google Ads, Healthcare and medicines policy, US section, checked October 24, 2026)
The Prescription drug services page, which names “online pharmacies and telemedicine providers” as covered businesses, adds: “Advertisers must be certified by Google in order to serve ads for prescription drug services.”
The two certifications, in order: a US checklist
LegitScript comes first, because Google’s form asks for the certified domain. The sequence for one US GLP-1 telehealth brand:
- Get LegitScript telemedicine certification for the domain you’ll advertise. LegitScript prices it as “a one-time application fee and annual certification fee per website.” We cover the amounts in what LegitScript certification costs and the timeline in how long LegitScript certification takes.
- Open Google’s healthcare application form (6099627). Choose the organization type “Prescription drug services provider (online pharmacy, telemedicine).”
- Pick “United States” under “Select the country where you hold the license.”
- Request the permission “Use prescription drug terms, including prescription opioid painkiller terms, in ad text, landing pages, or keywords.”
- Apply from the child account. Google says applications must be “made at the child account level, not the MCC (Manager Account) level.” Include the Google Ads customer ID and the certified domain.
- If an agency applies, attach proof of the relationship. Google asks agencies to “send documentation detailing your relationship with the advertiser or license holder.” An agency managing several brands applies per child account.
- Certify every location you target. Google wants you “certified to advertise in all the locations you’re targeting,” with a separate application for each location or group of locations. A US-only GLP-1 brand needs the US one.
Check the site before you submit: Google says denials can come from a website that isn’t “fully functional, globally accessible,” or that contains drug terms you aren’t certified for.
GLP-1 drug terms on Google’s prescription drug list
Most GLP-1 names a weight-loss brand would bid on are on Google’s prescription drug list, so keyword-targeting them needs certification. We searched Google’s non-exhaustive list for each term on October 24, 2026. Google calls the list examples, so treat the missing names as if they need certification too.
| Terms | On Google’s list (Oct 24, 2026) | US ad text and landing pages | US keyword targeting |
|---|---|---|---|
| semaglutide, Ozempic, Wegovy | Yes | Allowed under local law | Certification required |
| tirzepatide, Mounjaro, Zepbound | Yes | Allowed under local law | Certification required |
| liraglutide, Victoza | Yes | Allowed under local law | Certification required |
| exenatide, Byetta | Yes | Allowed under local law | Certification required |
| Saxenda, Rybelsus, dulaglutide, Trulicity, Bydureon | Not found | Not stated | Not stated |
The last two columns come from Google’s October 2025 change, posted October 14, 2025 and enforced from October 29, 2025. For the US, Canada and New Zealand, Restricted drug terms now says: “While you don’t need to be certified in order to use prescription drug terms in ads and landing pages, you must be certified in order to keyword-target these terms.” The same paragraph adds that certification “is also required for certain business types, like online pharmacies, telemedicine providers.” The ad-text column therefore doesn’t excuse a telehealth brand from certifying.
Allowed vs not allowed for a GLP-1 telehealth account
A certified US telemedicine account can do much more than an uncertified one, and a few things are off limits either way. Every row comes from Google’s policy pages, checked October 24, 2026.
| Ad element | Uncertified telehealth account | Certified (LegitScript + Google) |
|---|---|---|
| Serving ads for online prescribing services | Not allowed | Allowed |
| “Semaglutide” or “tirzepatide” in ad text or on the landing page | Business still needs certification as a telemedicine provider | Allowed under local law |
| Bidding on keywords like “semaglutide” or “Zepbound” | Not allowed | Allowed in the US |
| Applying for certification at MCC level | Not accepted | Not accepted (apply per child account) |
| Targeting locations where you aren’t licensed | Not allowed | Not allowed |
| Offering prescription drugs without a prescription | Not allowed, “egregious” | Not allowed, “egregious” |
The last two rows come from Google’s Unauthorized pharmacies rules, which say “Targeting locations where you aren’t licensed is not allowed” and call violations “egregious,” with suspension “upon detection and without prior warning.” For a US telehealth brand, the safe reading is to geo-target only the states where your clinicians can prescribe.
Why certified GLP-1 ads still get disapproved
Certification doesn’t exempt individual ads from review. Panelists at LegitScript’s telehealth advertising webinar (recap published May 13, 2026) listed the most common reasons health ads get rejected across the major ad platforms:
- “Unsubstantiated claims”
- “Missing disclosures”
- “Mentions of restricted drug names”
- “Before-and-after imagery”
For compounded GLP-1 offers, LegitScript’s panel said compounded versions “are not the same as branded versions,” and copy that implies equivalence falls outside FDA guidance. The FDA has acted on the same issue. On March 3, 2026 it announced “30 warning letters to telehealth companies,” citing “claims implying sameness with FDA-approved products.”
The same panel said that if one campaign mixes OTC and prescription products, “the entire campaign must meet pharmaceutical advertising standards.” Split them into separate campaigns and landing pages. We hold the GLP-1 creative we build for brands on Meta, Outbrain and TikTok to the same four checks.
What to do if your application or ads are rejected
Google’s official routes after a rejection are to fix the issue and reapply, reply to the rejection email, or appeal from inside the account.
- If the application is denied, read the denial reason. Google says to “make necessary changes and reapply, or reply to the rejection email with explanations if you believe it’s an error.”
- If an ad is disapproved, edit the ad or switch to a compliant landing page and save. Google reviews it again automatically (Fix ads with policy violations).
- If you think Google got it wrong, appeal from inside the account. If you can’t fix an ad, remove it, because Google warns that repeated violations can lead to suspension.
For problems with the LegitScript certification itself, Google’s policy page sends you to the LegitScript team.
FAQ
Is Google healthcare certification the same as LegitScript?
No. LegitScript is a third-party accreditation of your website. Google’s certification is a separate approval of your Google Ads account, and for US telemedicine you need LegitScript before you apply to Google.
Can an agency apply for a brand?
Yes. It applies at the brand’s child account and sends documentation of its relationship with the advertiser or license holder.
How much does Google Ads healthcare certification cost?
None of Google’s policy or application pages we checked on October 24, 2026 lists a fee for Google’s own step. The cost comes from LegitScript, which charges an application fee plus an annual fee per website.
Sources
- Google Ads, Healthcare and medicines policy · accessed
- Google Ads, Prescription drug services · accessed
- Google Ads, Restricted drug terms · accessed
- Google Ads, Update to Healthcare and Medicines Policy (October 2025), posted October 14, 2025 · accessed
- Google Ads, Prescription drugs list · accessed
- Google Ads, healthcare certification application form · accessed
- Google Ads, Fix ads with policy violations · accessed
- LegitScript, Telemedicine certification · accessed
- LegitScript, Certified But Still Getting Disapproved? Webinar takeaways (May 13, 2026) · accessed
- FDA, FDA Warns 30 Telehealth Companies Against Illegal Marketing of Compounded GLP-1s (March 3, 2026) · accessed